The  	The  	 DT	O
history  	history  	 NN	O
of  	of  	 IN	O
sublingual  	sublingual  	 NNS	B-NP
immunotherapy  	immunotherapy  	 VBP	O
The  	The  	 DT	O
sublingual  	sublingual  	 JJ	B-NP
route  	route  	 NN	I-NP
of  	of  	 IN	I-NP
administration  	administration  	 NN	I-NP
of  	of  	 IN	O
allergen  	allergen  	 NNS	O
( 	( 	 -LRB-	O
SLIT 	SLIT 	 NNP	O
)  	)  	 -RRB-	O
has  	has  	 VBZ	O
emerged  	emerged  	 VBN	O
as  	as  	 IN	O
an  	an  	 DT	O
effective  	effective  	 JJ	O
treatment 	treatment 	 NN	O
.  	.  	 .	O
Other  	Other  	 JJ	B-NP
non-injective  	non-injective  	 JJ	I-NP
route  	route  	 NN	I-NP
of  	of  	 IN	I-NP
administration  	administration  	 NN	I-NP
of  	of  	 IN	O
vaccines  	vaccines  	 NNS	O
failed  	failed  	 VBD	O
their  	their  	 PRP$	O
goals 	goals 	 NNS	O
;  	;  	 :	O
oral  	oral  	 JJ	B-NP
immunotherapy  	immunotherapy  	 NNS	I-NP
( 	( 	 -LRB-	O
OIT 	OIT 	 NNP	B-NP
) 	) 	 -RRB-	O
,  	,  	 ,	O
local  	local  	 JJ	B-NP
nasal  	nasal  	 JJ	I-NP
immunotherapy  	immunotherapy  	 NNS	I-NP
( 	( 	 -LRB-	O
LNIT 	LNIT 	 NNP	B-NP
) 	) 	 -RRB-	O
,  	,  	 ,	O
local  	local  	 JJ	B-NP
bronchial  	bronchial  	 JJ	I-NP
immunotherapy  	immunotherapy  	 NNS	I-NP
( 	( 	 -LRB-	O
LBIT 	LBIT 	 NNP	B-NP
)  	)  	 -RRB-	O
were  	were  	 VBD	O
reported  	reported  	 VBN	O
as  	as  	 IN	O
too  	too  	 RB	O
expensive  	expensive  	 JJ	O
or  	or  	 CC	O
unsafe  	unsafe  	 JJ	O
or  	or  	 CC	O
ineffective 	ineffective 	 JJ	O
.  	.  	 .	O
Oral  	Oral  	 JJ	B-NP
regimens  	regimens  	 NN	I-NP
were  	were  	 VBD	O
used  	used  	 VBN	O
in  	in  	 IN	O
the  	the  	 DT	O
first  	first  	 JJ	O
half  	half  	 NN	O
of  	of  	 IN	O
the  	the  	 DT	O
20th  	20th  	 JJ	O
century  	century  	 NN	O
but  	but  	 CC	O
then  	then  	 RB	O
they  	they  	 PRP	O
lost  	lost  	 VBD	O
ground  	ground  	 NN	O
to  	to  	 TO	O
injection  	injection  	 VB	B-NP
immunotherapy 	immunotherapy 	 NNS	I-NP
.  	.  	 .	O
SLIT  	SLIT  	 NNP	O
is  	is  	 VBZ	O
suitable  	suitable  	 VBN	O
for  	for  	 IN	O
home  	home  	 NN	B-NP
treatment  	treatment  	 NN	I-NP
and  	and  	 CC	O
it  	it  	 PRP	O
has  	has  	 VBZ	O
not  	not  	 RB	O
to  	to  	 TO	O
be  	be  	 VB	O
regarded  	regarded  	 VBN	O
not  	not  	 RB	O
only  	only  	 RB	O
as  	as  	 IN	O
a  	a  	 DT	O
substitute  	substitute  	 NN	O
of  	of  	 IN	O
subcutaneous  	subcutaneous  	 JJ	B-NP
immunotherapy  	immunotherapy  	 NNS	I-NP
( 	( 	 -LRB-	O
SCIT 	SCIT 	 NNP	B-NP
) 	) 	 -RRB-	O
,  	,  	 ,	O
but  	but  	 CC	O
also  	also  	 RB	O
as  	as  	 IN	O
a  	a  	 DT	O
complementary  	complementary  	 JJ	O
or  	or  	 CC	O
additional  	additional  	 JJ	O
therapeutic  	therapeutic  	 JJ	B-NP
tool  	tool  	 NN	I-NP
in  	in  	 IN	O
conventional  	conventional  	 JJ	B-NP
medical  	medical  	 JJ	I-NP
practice 	practice 	 NN	I-NP
.  	.  	 .	O
Currently 	Currently 	 RB	O
,  	,  	 ,	O
the  	the  	 DT	O
balance  	balance  	 NN	B-NP
sheet  	sheet  	 NN	I-NP
for  	for  	 IN	O
SLIT  	SLIT  	 NNP	O
is  	is  	 VBZ	O
improving 	improving 	 VBG	O
:  	:  	 :	O
with  	with  	 IN	O
the  	the  	 DT	O
steadily  	steadily  	 RB	O
increasing  	increasing  	 VBG	O
number  	number  	 NN	O
of  	of  	 IN	O
patients  	patients  	 NNS	O
with  	with  	 IN	O
IgE  	IgE  	 JJ	B-NP
mediated  	mediated  	 JJ	I-NP
disorders 	disorders 	 NNS	I-NP
,  	,  	 ,	O
looking  	looking  	 VBG	O
for  	for  	 IN	O
a  	a  	 DT	O
cheap 	cheap 	 JJ	O
,  	,  	 ,	O
safe  	safe  	 JJ	O
and  	and  	 CC	O
effective  	effective  	 JJ	O
therapy  	therapy  	 NN	O
becomes  	becomes  	 VBZ	O
a  	a  	 DT	O
priority 	priority 	 NN	O
.  	.  	 .	O
